Skip to main content

How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey.

Publication ,  Journal Article
Guignant, M; Tedbirt, B; Murrell, DF; Amagai, M; Aoki, V; Bauer, J; Ciancinni, G; Culton, D; Daneshpazhooh, M; De, D; Fairley, J; Hall, R ...
Published in: JID Innov
July 2022

Many treatments are currently proposed for treating patients with bullous pemphigoid (BP). We assessed treatment modalities of BP depending on the different countries, BP extent, and patients' comorbidities. We surveyed worldwide experts about how they treat patients with BP. A total of 61 experts from 27 countries completed the survey. Severe and moderate BP were treated with oral prednisone (61.4 and 53.7%, respectively) or superpotent topical corticosteroids (CSs) (38.6 and 46.3%, respectively). Conventional immunosuppressants were more frequently combined with oral prednisone (74.5%) than with superpotent topical CS (37.5%) in severe BP. Topical CSs were mainly used in Europe in mild (81.1%), moderate (55.3%), and severe (54.3%) BP. In the United States of America and Asia, systemic CSs were mainly proposed for treating severe (77.8 and 100%, respectively), moderate (70 and 77.8%, respectively), and also mild (47.1 and 33.3%, respectively) BP. Most experts reduced the initial dose of oral CS in patients with diabetes mellitus (48.1%) or cardiac insufficiency (40.2%) but rarely changed BP treatment in patients with neurological disorders or neoplasia. This survey showed major differences in the way patients with BP are treated between AmeriPac countries (United State of America, Latin America, and Australia) and Asia on the one hand and Europe and the Middle East on the other hand.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JID Innov

DOI

EISSN

2667-0267

Publication Date

July 2022

Volume

2

Issue

4

Start / End Page

100129

Location

Netherlands
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Guignant, M., Tedbirt, B., Murrell, D. F., Amagai, M., Aoki, V., Bauer, J., … Joly, P. (2022). How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey. JID Innov, 2(4), 100129. https://doi.org/10.1016/j.xjidi.2022.100129
Guignant, Marine, Billal Tedbirt, Dedee F. Murrell, Masayuki Amagai, Valeria Aoki, Johannes Bauer, Giuseppe Ciancinni, et al. “How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey.JID Innov 2, no. 4 (July 2022): 100129. https://doi.org/10.1016/j.xjidi.2022.100129.
Guignant M, Tedbirt B, Murrell DF, Amagai M, Aoki V, Bauer J, et al. How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey. JID Innov. 2022 Jul;2(4):100129.
Guignant, Marine, et al. “How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey.JID Innov, vol. 2, no. 4, July 2022, p. 100129. Pubmed, doi:10.1016/j.xjidi.2022.100129.
Guignant M, Tedbirt B, Murrell DF, Amagai M, Aoki V, Bauer J, Ciancinni G, Culton D, Daneshpazhooh M, De D, Fairley J, Hall R, Kim S-C, Korman NJ, Kowalewski C, Mimouni D, Patsatsi A, Hebert V, Saleh MAM, Schmidt E, Sprecher E, Uzun S, Venning V, Werth VP, Zillikens D, Joly P. How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey. JID Innov. 2022 Jul;2(4):100129.

Published In

JID Innov

DOI

EISSN

2667-0267

Publication Date

July 2022

Volume

2

Issue

4

Start / End Page

100129

Location

Netherlands